Schizophrenia Researchers in Los Angeles


If you or someone you love are living with schizophrenia, you may qualify for a clinical research trial testing the effectiveness and safety of CTP-692, an investigational medication working as an adjunctive treatment. Adjunctive therapies work with your current treatment regimen, meaning you DO NOT have to give up your current treatment options.

You or your loved one may qualify for participation if you/they:
  • Are between the ages of 18 and 55.
  • Have a physician-confirmed DSM-V diagnosis of schizophrenia.
  • Are already taking one antipsychotic medication.
You or your loved one may qualify for participation if you/they:
  • Are currently taking clozapine.
  • Have moderate to severe drug or alcohol substance use disorder in the past 6 months.
    • Please note, this does not include caffeine or nicotine.
  • Have a history of renal disease.
Do You Qualify?
What is Schizophrenia?
Schizophrenia is chronic psychotic disorder that affects 20 million people worldwide. Onset is typically during late adolescence or early adulthood, and is caused by many factors including genetic, environmental, or chemical. As the disorder progresses, symptoms may include delusions, hallucinations, disorganized speech, and disorganized behavior. Someone with schizophrenia might also suffer from a lack of normal behaviors such as emotional expression and interest/enthusiasm.
What is a Clinical Trial?
A clinical research trial tests the safety and effectiveness of a new medicine or treatment in a population of volunteers. Every medical breakthrough goes through the clinical trial process. Therefore, participants like you play a very important role in advancing medicine for present and future generations.
ProScience Research Group

6133 Bristol Parkway Suite 305
Culver City, CA 90230